tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Tvardi Therapeutics Ord Shs

TVRD
Add to Watchlist
1.320USD
-0.250-15.92%
Close 09-23 16:00（ET）
16.49MMarket Cap
0.20P/E TTM

Tvardi Therapeutics Ord Shs

1.320
-0.250-15.92%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

TVRD Financials

See Tvardi Therapeutics Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
16.49M
Dividend TTM
0.00
P/E TTM
0.20
EPS TTM
6.48
Revenue
--
Net Profit
-70.87M
ROE
-625.37%
ROA
-62.11%

Tvardi Therapeutics Ord Shs Earnings Date

Latest Release
Aug 14, 2026
EPS / Forecast
-0.69/-0.70
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
---0.69
---0.73
---0.77
---0.59
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
20.33%2.57M
-51.56%1.46M
-47.47%2.56M
-85.71%991.00K
-65.37%2.13M
-7.88%3.00M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
297.20%3.26M
-46.66%10.81M
--23.00M
147.55%4.79M
-99.27%821.00K
118.78%20.27M
-100.00%0.00
Net Profit
-254.96%-6.46M
-38.69%-6.80M
5.26%-7.28M
55.70%-5.53M
84.02%-4.91M
76.25%-7.68M
55.49%-12.48M
36.41%-20.02M
-15.12%-30.70M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.66M
9.12%-30.34M
-2188.25%-23.18M
86.32%-4.21M
-19.09%-27.75M
-142.30%-33.38M
93.86%-1.01M
-22.65%-30.75M
Debt to assets ratio
----
----
----
--0.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
----
----
----
----
20.33%2.57M
-51.56%1.46M
-47.47%2.56M
-85.71%991.00K
-65.37%2.13M
-7.88%3.00M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
297.20%3.26M
-46.66%10.81M
--23.00M
147.55%4.79M
-99.27%821.00K
118.78%20.27M
-100.00%0.00
Operating profit
25.26%-6.63M
-195.52%-7.05M
-36.78%-7.59M
-12.44%-5.94M
91.25%-2.39M
82.99%-5.55M
81.73%-5.28M
54.47%-14.72M
1.39%-27.27M
-4.15%-32.61M
-21.19%-28.90M
-623.17%-32.34M
0.94%-27.65M
6.61%-31.31M
-2021.44%-23.84M
85.52%-4.47M
-18.46%-27.91M
-142.82%-33.52M
93.40%-1.12M
-19.29%-30.88M
Net Profit
-254.96%-6.46M
-38.69%-6.80M
5.26%-7.28M
55.70%-5.53M
84.02%-4.91M
76.25%-7.68M
55.49%-12.48M
36.41%-20.02M
-15.12%-30.70M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.66M
9.12%-30.34M
-2188.25%-23.18M
86.32%-4.21M
-19.09%-27.75M
-142.30%-33.38M
93.86%-1.01M
-22.65%-30.75M
Balance Sheet
Current assets
-60.42%17.07M
-34.97%25.33M
-28.04%31.54M
-19.76%38.44M
-52.05%38.95M
-62.27%43.83M
-52.38%47.91M
-48.80%63.86M
-43.06%81.22M
-31.23%116.16M
-46.14%100.60M
-29.19%124.74M
-6.00%142.66M
-2.53%168.91M
8.91%186.78M
7.11%176.17M
-19.43%151.76M
-11.16%173.29M
29.10%171.50M
15.90%164.47M
Total current liabilities
-14.66%9.11M
838.95%11.26M
178.00%11.04M
9.97%11.04M
-92.06%1.20M
-84.48%3.97M
-56.13%10.04M
-45.39%13.90M
-9.49%15.10M
9.10%25.59M
-18.84%22.88M
20.27%25.46M
-8.84%16.68M
33.16%23.46M
81.56%28.19M
39.53%21.17M
10.76%18.30M
-4.69%17.62M
-6.45%15.53M
-38.65%15.17M
Total assets
-59.96%17.52M
-33.71%25.82M
-26.82%32.07M
-23.98%39.02M
-56.77%38.95M
-65.17%43.83M
-55.50%51.33M
-46.06%72.50M
-41.22%90.10M
-30.94%125.84M
-45.98%115.34M
-40.69%134.39M
-31.53%153.28M
-26.24%182.24M
-5.15%213.51M
2.31%226.57M
-10.54%223.87M
-8.89%247.06M
52.98%225.09M
31.34%221.45M
Total liabilities
-15.60%9.13M
-75.94%11.31M
-77.02%11.13M
-77.96%11.15M
-22.02%47.02M
-29.58%48.42M
70.47%50.62M
139.22%60.90M
261.53%60.30M
193.12%68.76M
3.51%29.70M
14.93%25.46M
-15.56%16.68M
20.09%23.46M
60.26%28.69M
23.14%22.15M
-0.09%19.75M
-11.83%19.53M
-7.20%17.90M
-35.03%17.99M
Total equity
-74.54%8.38M
279.67%14.51M
556.04%20.95M
3841.44%27.87M
-127.09%-8.07M
-108.05%-4.59M
-99.17%707.00K
-89.35%11.60M
-78.18%29.80M
-64.05%57.09M
-53.66%85.64M
-46.71%108.93M
-33.08%136.60M
-30.21%158.78M
-10.80%184.82M
0.47%204.42M
-11.43%204.12M
-8.63%227.52M
62.06%207.19M
44.38%203.47M
Cash Flow Statement
Net operating income
-4.09%-9.23M
-24.87%-5.86M
-40.61%-5.68M
69.56%-4.26M
84.59%-4.69M
76.72%-4.04M
28.82%-13.98M
39.17%-12.44M
12.03%-30.45M
26.12%-17.37M
22.02%-19.64M
-354.03%-20.45M
-35.62%-34.62M
-1788.35%-23.51M
-78.46%-25.19M
78.56%-4.50M
-7.61%-25.52M
-101.52%-1.25M
34.71%-14.12M
24.04%-21.00M
Net investment
125.17%5.14M
--4.98M
0.00%5.00M
113.96%5.35M
-100.00%0.00
116.55%5.00M
-89.20%2.50M
-53.39%15.29M
46.55%25.95M
-167.99%-30.20M
9.35%23.16M
10.53%32.80M
-47.03%17.71M
182.91%44.42M
46.72%21.18M
44.57%29.68M
141.05%33.43M
67.36%-53.58M
-63.50%14.43M
-69.53%20.53M
Net financing
----
----
100.06%1.00K
53.60%-322.00K
246.86%1.01M
-104.43%-1.61M
-162.19%-694.00K
---610.00K
-222.32%-685.00K
165695.45%36.48M
973.08%1.12M
-100.00%0.00
18566.67%560.00K
-99.95%22.00K
-69.32%104.00K
-37.88%182.00K
-99.56%3.00K
17.73%45.29M
-14.18%339.00K
45.77%293.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its current assets were 31.54M, with a year-on-year change of -0.47.

What are the total assets of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its total assets of Tvardi Therapeutics Ord Shs were 32.07M, with a year-on-year change of -8.88.

What are the total liabilities of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its total liabilities of Tvardi Therapeutics Ord Shs were 11.13M, with a year-on-year change of -72.75.

What is the total equity of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its total equity of Tvardi Therapeutics Ord Shs was 20.95M, with a year-on-year change of 472.17.

What is the net operating income of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its net operating income of Tvardi Therapeutics Ord Shs was -26.75M, with a year-on-year change of 4.84.

What is the net investment of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its net investment of Tvardi Therapeutics Ord Shs was -10.08M, with a year-on-year change of -120.69.

What is the net financing of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its net financing of Tvardi Therapeutics Ord Shs was 22.70M, with a year-on-year change of -15.91.

What is the Earnings Per Share (EPS) of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -2.46, with a year-on-year change of 78.50.

What is the net income of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its net income was -18.21M, with a year-on-year change of 38.04.

What is the Return on Assets (ROA) of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -54.15, with a year-on-year change of -48.32.

What is the operating profit of Tvardi Therapeutics Ord Shs?

According to Tvardi Therapeutics Ord Shs's FY2025 earnings report, its operating profit was -26.75M, with a year-on-year change of 4.84.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy